111In-PSMA-Trillium

N/A

Report date: 2026/04/03 20:03:44

Base Information

Drug Name111In-PSMA-Trillium
Drug Alias NameBAY3632687BAY-3632687
ClassificationSmall moleculesRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Nuclides > Indium > 111In +[4] 
Mechanisms of ActionProstate-Specific Membrane Antigen modulators
TargetsProstate-Specific Membrane Antigen
Therapy Area/IndicationsProstatismProstatic Neoplasms, Castration-Resistant
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[10] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesBayer AG
Inactive CompaniesN/A
Active IndicationsProstatismProstatic Neoplasms, Castration-Resistant
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A